As previous studies revealed that an increased tumor lesion HLA-F expression has been associated with poor prognosis in patients with gliomas (71), nasopharyngeal carcinoma (26), stage II breast cancer (72), and esophageal squamous cell carcinoma (19). Here, HLA-F is linked to neoplasm.